4.6 Review

Re-analysis of genomic data: An overview of the mechanisms and complexities of clinical adoption

Journal

GENETICS IN MEDICINE
Volume 24, Issue 4, Pages 798-810

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.gim.2021.12.011

Keywords

Clinical genomics; Curation; Genomics; Re-analysis; Sequence analysis

Ask authors/readers for more resources

Re-analyzing genomic information from patients can enhance diagnostic yield of sequencing tests, but it comes with complexities and challenges such as terminology, increased workload, reimbursement pathways, and ethical implications. This review proposes a terminology, identifies mechanisms for increasing diagnostic yield, and provides insights into the challenges faced by healthcare systems and individual patients.
Re-analyzing genomic information from a patient suspected of having an underlying genetic condition can improve the diagnostic yield of sequencing tests, potentially providing significant benefits to the patient and to the health care system. Although a significant number of studies have shown the clinical potential of re-analysis, less work has been performed to characterize the mechanisms responsible for driving the increases in diagnostic yield. Complexities surrounding re-analysis have also emerged. The terminology itself represents a challenge because re-analysis can refer to a range of different concepts. Other challenges include the increased workload that re-analysis demands of curators, adequate reimbursement pathways for clinical and diagnostic services, and the development of systems to handle large volumes of data. Re-analysis also raises ethical implications for patients and families, most notably when re-classification of a variant alters diagnosis, treatment, and prognosis. This review highlights the possibilities and complexities associated with the re-analysis of existing clinical genomic data. We propose a terminology that builds on the foundation presented in a recent statement from the American College of Medical Genetics and Genomics and describes each reanalysis process. We identify mechanisms for increasing diagnostic yield and provide perspectives on the range of challenges that must be addressed by health care systems and individual patients. (C) 2022 The Authors. Published by Elsevier Inc. on behalf of American College of Medical Genetics and Genomics.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available